REGISTRATION CONFIRMATION
Thank you for registering for our TeleECHO Session. Please see program details below. Login information is provided below and will also be sent to you via the email you provided during registration. Please extend the invite to your colleagues.
Novel Therapeutic Perspectives in the Management of DLBCL: The Role of Antibody-Drug Conjugates and Bispecific Antibodies
Monday, June 6, 2022
1:00PM – 2:00PM ET
Please note this TeleECHO program is 1:00PM Eastern, 12:00PM Central, 11:00AM Mountain and 10:00AM Pacific.
You can find more information about this program at https://www.medlearninggroup.com/cme-programming/dlbc-echo2
Register a colleague at https://www.medlearninggroup.com/cme-programming/dlbc-echo2-registration
1) PARTICIPATION INSTRUCTIONS
LOGIN INFORMATION
Join Zoom Meeting
https://us02web.zoom.us/j/88245523433
Meeting ID: 882 4552 3433
One tap mobile
+13126266799,,88245523433# US (Chicago)
+19292056099,,88245523433# US (New York)
Dial by your location
+1 312 626 6799 US (Chicago)
+1 929 205 6099 US (New York)
+1 301 715 8592 US (Washington DC)
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
888 788 0099 US Toll-free
833 548 0276 US Toll-free
833 548 0282 US Toll-free
877 853 5247 US Toll-free
Meeting ID: 882 4552 3433
Find your local number: https://us02web.zoom.us/u/kcsJpX4Ed6
Should you have any questions or concerns, please contact us at any time.
Sincerely,
Joseph L. Guerriero, MBA
Director of Educational Solutions
Med Learning Group
9309 N. Florida Ave., Suite 100
Tampa, FL 33612
Phone: 908-358-6466
[email protected]
www.medlearninggroup.com